AMI, Pharm AMI Pharm South Korea 11.08.2025 - 09:01:15 AMI Pharm Advances AYP-101 to Phase 3, Redefining Fat-Reduction Injectable drug with Patient Comfort in Focus View original content:https://www.prnewswire.co.uk/news-releases/ami-pharm-advances-ayp-101-to-phase-3-redefining-fat-reduction-injectable-drug-with-patient-comfort-in-focus-302522991.html
